Cargando…

Our Experience with Using WatchPat® (Itamar Medical, Ltd.), Home Sleep Testing (HST) for the Diagnosis of Sleep Apnea in Advanced Heart Failure Patients

INTRODUCTION: Sleep apnea is widely reported as an independent predictor for the development of heart failure (HF), with a 2.6-fold increase in incidence after adjusting for age, sex, body mass index (BMI) and smoking. The accepted gold standard for sleep apnea diagnosis is polysomnography (PSG); ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Carey, Sandra A., Afzal, Aasim, Jamil, Aayla, Whiteley, Whitney, Ostransky, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527180/
http://dx.doi.org/10.1016/j.cardfail.2020.09.026
_version_ 1783589002342825984
author Carey, Sandra A.
Afzal, Aasim
Jamil, Aayla
Whiteley, Whitney
Ostransky, David
author_facet Carey, Sandra A.
Afzal, Aasim
Jamil, Aayla
Whiteley, Whitney
Ostransky, David
author_sort Carey, Sandra A.
collection PubMed
description INTRODUCTION: Sleep apnea is widely reported as an independent predictor for the development of heart failure (HF), with a 2.6-fold increase in incidence after adjusting for age, sex, body mass index (BMI) and smoking. The accepted gold standard for sleep apnea diagnosis is polysomnography (PSG); however, access to PSG is limited and more so in the COVID-19 pandemic crisis. WatchPAT Home Sleep Testing (WPHST) has been validated to accurately detect both obstructive (OSA) as well as central sleep apnea (CSA) in the general population. However, to date no studies have reported its use in the advanced HF population. METHODS: This was a single center, retrospective, observational analysis, beginning December of 2019-April 2020. All subjects that screened positive on the STOP-BANG sleep apnea questionnaire and assigned the HST were analyzed. RESULTS: 62 subjects (HF, LVAD, Orthotopic Heart Transplant [OHT]) were assigned HST. 93% (n=58) completed testing. 77% (n=7/9) of patients with LVAD had testing that was deemed inconclusive, thus patients with LVAD were censored from our analysis. Of the 44 patients that tested positive for at least mild OSA, 32 % (n=14) of the patients were post OHT. Over 45% of both OHT and HF patients tested, were documented to have severe sleep apnea (See table(1)). DISCUSSION: WatchPat® is the only HST that proports calculations of total sleep time. It appears to be a viable option for advanced HF and OHT patients with limited access to in-lab PSG. However, WPHST was unable to provide conclusive data for LVAD patients, hypothesized due to lack of native pulsatility. Strikingly, severe sleep apnea was documented in >45% of all patients, and no significant differences when comparing OHT patients to the advanced heart failure population. Continued research and emphasis on testing and treatment of HF patients being considered for advanced therapies is warranted, especially with the current proclivity towards minimum contact post Covid19.
format Online
Article
Text
id pubmed-7527180
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-75271802020-10-01 Our Experience with Using WatchPat® (Itamar Medical, Ltd.), Home Sleep Testing (HST) for the Diagnosis of Sleep Apnea in Advanced Heart Failure Patients Carey, Sandra A. Afzal, Aasim Jamil, Aayla Whiteley, Whitney Ostransky, David J Card Fail 011 INTRODUCTION: Sleep apnea is widely reported as an independent predictor for the development of heart failure (HF), with a 2.6-fold increase in incidence after adjusting for age, sex, body mass index (BMI) and smoking. The accepted gold standard for sleep apnea diagnosis is polysomnography (PSG); however, access to PSG is limited and more so in the COVID-19 pandemic crisis. WatchPAT Home Sleep Testing (WPHST) has been validated to accurately detect both obstructive (OSA) as well as central sleep apnea (CSA) in the general population. However, to date no studies have reported its use in the advanced HF population. METHODS: This was a single center, retrospective, observational analysis, beginning December of 2019-April 2020. All subjects that screened positive on the STOP-BANG sleep apnea questionnaire and assigned the HST were analyzed. RESULTS: 62 subjects (HF, LVAD, Orthotopic Heart Transplant [OHT]) were assigned HST. 93% (n=58) completed testing. 77% (n=7/9) of patients with LVAD had testing that was deemed inconclusive, thus patients with LVAD were censored from our analysis. Of the 44 patients that tested positive for at least mild OSA, 32 % (n=14) of the patients were post OHT. Over 45% of both OHT and HF patients tested, were documented to have severe sleep apnea (See table(1)). DISCUSSION: WatchPat® is the only HST that proports calculations of total sleep time. It appears to be a viable option for advanced HF and OHT patients with limited access to in-lab PSG. However, WPHST was unable to provide conclusive data for LVAD patients, hypothesized due to lack of native pulsatility. Strikingly, severe sleep apnea was documented in >45% of all patients, and no significant differences when comparing OHT patients to the advanced heart failure population. Continued research and emphasis on testing and treatment of HF patients being considered for advanced therapies is warranted, especially with the current proclivity towards minimum contact post Covid19. Published by Elsevier Inc. 2020-10 2020-09-30 /pmc/articles/PMC7527180/ http://dx.doi.org/10.1016/j.cardfail.2020.09.026 Text en Copyright © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 011
Carey, Sandra A.
Afzal, Aasim
Jamil, Aayla
Whiteley, Whitney
Ostransky, David
Our Experience with Using WatchPat® (Itamar Medical, Ltd.), Home Sleep Testing (HST) for the Diagnosis of Sleep Apnea in Advanced Heart Failure Patients
title Our Experience with Using WatchPat® (Itamar Medical, Ltd.), Home Sleep Testing (HST) for the Diagnosis of Sleep Apnea in Advanced Heart Failure Patients
title_full Our Experience with Using WatchPat® (Itamar Medical, Ltd.), Home Sleep Testing (HST) for the Diagnosis of Sleep Apnea in Advanced Heart Failure Patients
title_fullStr Our Experience with Using WatchPat® (Itamar Medical, Ltd.), Home Sleep Testing (HST) for the Diagnosis of Sleep Apnea in Advanced Heart Failure Patients
title_full_unstemmed Our Experience with Using WatchPat® (Itamar Medical, Ltd.), Home Sleep Testing (HST) for the Diagnosis of Sleep Apnea in Advanced Heart Failure Patients
title_short Our Experience with Using WatchPat® (Itamar Medical, Ltd.), Home Sleep Testing (HST) for the Diagnosis of Sleep Apnea in Advanced Heart Failure Patients
title_sort our experience with using watchpat® (itamar medical, ltd.), home sleep testing (hst) for the diagnosis of sleep apnea in advanced heart failure patients
topic 011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527180/
http://dx.doi.org/10.1016/j.cardfail.2020.09.026
work_keys_str_mv AT careysandraa ourexperiencewithusingwatchpatitamarmedicalltdhomesleeptestinghstforthediagnosisofsleepapneainadvancedheartfailurepatients
AT afzalaasim ourexperiencewithusingwatchpatitamarmedicalltdhomesleeptestinghstforthediagnosisofsleepapneainadvancedheartfailurepatients
AT jamilaayla ourexperiencewithusingwatchpatitamarmedicalltdhomesleeptestinghstforthediagnosisofsleepapneainadvancedheartfailurepatients
AT whiteleywhitney ourexperiencewithusingwatchpatitamarmedicalltdhomesleeptestinghstforthediagnosisofsleepapneainadvancedheartfailurepatients
AT ostranskydavid ourexperiencewithusingwatchpatitamarmedicalltdhomesleeptestinghstforthediagnosisofsleepapneainadvancedheartfailurepatients